Cancer remains one of the most formidable challenges in modern medicine. Despite decades of research and advancements in treatments like chemotherapy and radiation, many patients still face treatment failures, recurrences and aggressive forms of the disease.
In a groundbreaking "Health Ranger Report" interview on Brighteon.com, the Health Ranger Mike Adams, founder of Brighteon and a leading voice in health and wellness, sat down with investigative journalist Jonathan Otto, producer of the "Cancer Secrets" documentary series, to explore the hidden mechanisms driving cancer and the innovative strategies that could revolutionize treatment.
Chemotherapy and radiation are designed to kill rapidly dividing tumor cells. However, these treatments often fail to address cancer stem cells—the "rudder of the ship," as Otto described them. These cells are responsible for driving tumor growth, metastasis and recurrence.
The filmmaker and humanitarian mentioned that chemotherapy kills tumor cells, but it enhances and strengthens cancer stem cells which act like the rudder that control the growth of the tumor. (Related: Chemotherapy found to increase the number of tumor cells circulating in the blood, spreading it to previously unaffected areas)
Cancer stem cells are undifferentiated, meaning they haven't fully matured into specific cell types. This makes them resistant to conventional therapies, which target more developed cancer cells. Otto emphasized that understanding and reprogramming these cells is key to achieving lasting remission.
One of the most promising approaches to targeting cancer stem cells involves oxygen-based therapies. Otto highlighted the work of Dr. Andreas Kalcker, whose clinic in Guadalajara, Mexico, has reported a 60 to 70 percent success rate in achieving remission for late-stage cancers using chlorine dioxide, a compound that delivers oxygen to the body.
Otto said that chlorine dioxide delivers 10.7 million oxygen molecules for every red blood cell in the body and an oxygen-rich environment is toxic to cancer cells, but it revitalizes healthy cells.
Red light therapy is another game-changer. Clinical trials have shown that specific wavelengths of red light can induce apoptosis (programmed cell death) in cancer cells. In one study, all participants with cutaneous T-cell lymphoma achieved complete remission after just two sessions of red-light therapy combined with a photosensitizing agent.
Otto pointed out that red light produces reactive oxygen species like singlet oxygen, which scavenge and destroy diseased cells.
Detoxification also plays a crucial role. Otto and Adams stress the importance of removing toxins – such as heavy metals, environmental pollutants and parasites – that contribute to cancer development. Simple, cost-effective protocols like parasite cleanses, liver detoxes and dietary changes can significantly improve outcomes.
Both Adams and Otto emphasized that fear is a major barrier to healing.
"Fear causes inflammation, and inflammation drives cancer," Adams said, noting that eliminating fear is one of the pathways to not get cancer. Otto added that education is the foundation of effective treatment, and he stressed the importance of having knowledge and being educated.
Adams and Otto also advocated for a holistic approach that addresses the root causes of cancer rather than just its symptoms. This includes nutrition sunlight and red-light therapy, detoxification, and emotional and mental health.
Cancer stem cells are the hidden culprits behind treatment failures, but they also represent a new frontier in cancer therapy. By targeting these cells with oxygen-based therapies, red light treatments and detox protocols, patients can achieve lasting remission and reclaim their health.
Follow Cancer.news for more news about cancer treatments.
Watch the video below to know more about the interview of Jonathan Otto with Mike Adams.
This video is from the Health Ranger Report channel on Brighteon.com.
Cancer treatments HARM patients: Radiotherapy can cause aggravated lung injury – study.
Light therapy found to destroy prostate cancer in new clinical trial.
Sources include: